Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like Epizyme Falls as Investors Take in Disappointing Phase II Data June 14, 2017 Henry Schein Announces Exclusive Distribution Agreement For s CardioSleeve February 21, 2017 4 Clinical Projects Shelved From Pfizer???s Pipeline August 1, 2017
